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A Glucose Sensing System Based 
on Transmission Measurements at 
Millimetre Waves using Micro strip 
Patch Antennas
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Gouzouasis1,2, Maria Koutsoupidou2, George Palikaras1, Richard Mackenzie3, Thomas Reeve3, 
Panagiotis Kosmas2 & Efthymios Kallos1
We present a sensing system operating at millimetre (mm) waves in transmission mode that can 
measure glucose level changes based on the complex permittivity changes across the signal path. The 
permittivity of a sample can change significantly as the concentration of one of its substances varies: 
for example, blood permittivity depends on the blood glucose levels. The proposed sensing system 
uses two facing microstrip patch antennas operating at 60 GHz, which are placed across interrogated 
samples. The measured transmission coefficient depends on the permittivity change along the signal 
path, which can be correlated to the change in concentration of a substance. Along with theoretical 
estimations, we experimentally demonstrate the sensing performance of the system using controlled 
laboratory samples, such as water-based glucose-loaded liquid samples. We also present results of 
successful glucose spike detection in humans during an in-vivo Intravenous Glucose Tolerance Test 
(IVGTT). The system could eventually be developed into a non-invasive glucose monitor for continuous 
monitoring of glucose levels for people living with diabetes, as it can detect as small as 1.33 mmol/l 
(0.025 wt%) glucose concentrations in the controlled water-based samples satisfactorily, which is well 
below the typical human glucose levels of 4 mmol/l.
The millimetre (mm) wave band of the electromagnetic (EM) spectrum offers valuable spectroscopy methods 
for material characterization1–3. The characterization can be performed in free space and does not require very 
precise alignment, as is the case for optical frequencies. Moreover, the mm frequency range is ideal for character-
ization of composites with scale of homogeneity in the order of millimetres1.
Quasi-optical setups have been used recently for dielectric measurements to detect the water contents of rocks 
and oils1. The measurement system proposed in ref. 1 is based on waveguides and requires additional components 
such as lens, filters, etc., which lead to additional complexity. Coplanar waveguide devices have also been used 
for dielectric spectroscopy of biological samples at 40 Hz–26.5 GHz2 by placing a liquid sample on the waveguide 
structure, thereby providing an accurate but non-invasive technique. Moreover, two-beam polarization interfer-
ometry spectroscopy has been used up to 300 GHz to characterize the dielectric constants of low loss polymer 
samples, where a complex setup including polarizer, mirror, and beam splitter has been used to perform the 
measurements. In addition to material characterization, mm-wave spectroscopy in reflection mode has also been 
used to detect sugar or glucose levels in water or blood, in the frequency spectrum of 33–95 GHz4.
To date, most commercially available glucose measurement methods are invasive by relying on drawing blood, 
and thus patients do not test as often as required for the proper management of diabetes. Non-invasive contin-
uous glucose monitoring devices have been sought after for more than four decades5. With regard to glucose 
sensing in particular, various methods utilizing optical or lower frequency EM waves have been examined in the 
past6–9. For example, a dielectric resonator operating at 1.68 GHz has been developed to detect glucose changes 
based in its resonant frequency changes9, but with a detection resolution (5 mg/ml) that is much lower than that 
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required for humans. The mm-wave band is particularly attractive for this application7, 8, 10, as the wavelength is 
short enough for a relatively compact antenna sensor, and the penetration depth is large enough for interrogation 
of thin human tissue regions with sufficient blood concentration. Mm-wave spectroscopy in reflection mode has 
been used for non-invasive glucose sensing through human skin7. A challenge in reflection-based detection is that 
the signal barely reaches the blood area and this minimal interaction may yield information that is not sufficient 
to detect small changes in glucose levels. To take advantage of transmission data, a sensor operating at K band 
(27–40 GHz) has been developed to detect glucose level in blood non-invasively8. The device used waveguide 
fixtures and was tested in rats on tissue of 0.5 mm thickness, which is much thinner than typical human tissue 
(2–3 mm).
To assess the possibility of detecting glucose by mm-wave technology, a measurement system using 
WR-15 V-band waveguides operating at 50–75 GHz has been demonstrated by the authors10. The system used 
transmission data to detect glucose concentration changes of clinical relevance in either pure water or saline 
solutions. The samples were contained in an acrylic tank which was sandwiched between two open waveguides. 
However, the dimensions of this measurement system were large, and the experimental setup required sophis-
ticated alignment to accurately measure the transmission and reflection coefficients. Therefore, the bulky wave-
guides must be replaced by compact planar antennas with mm dimensions in order to develop a compact and 
miniature sensor which is comfortable and easy to use by patients.
This paper describes a sensing system towards the realization of a handheld device, which can detect complex 
permittivity variations and correlate them to changes in the concentration of a specific substance, such as glucose 
concentration in water or blood. A pair of patch antennas tuned to operate around 60 GHz has been designed 
and fabricated to replace the earlier-used waveguide structures. These antennas are mounted on an experimental 
setup for measuring transmission across an acrylic tank filled with controlled water-based glucose solutions using 
micro-positioners and 3D-printed sample holders. The micro positioners can align the antenna against each other 
precisely to maximize the transmission across the tank. A schematic view of the proposed detection principle 
is shown in Fig. 1(a), where two identical antennas are placed across the sample of interest, e.g. human tissue. 
The antenna sensors are mounted inside a U-shaped casing and the area under measurements (AUM) is placed 
in-between the extended arms of the casing11. Other than the RF components, the sensor as shown in Fig. 1(b) 
also includes additional environmental sensors to monitor the impact of external factors such as motion and 
temperature. Precise measurements and data interpretation are achieved by an algorithm which integrates the 
data from the antennas and the complimentary sensors and translates this information into detection of glucose 
level variations.
The paper consists of three parts. First, a theoretical estimation of the system’s optimal frequency to maximize 
the sensitivity of detecting glucose levels within the uncertainty limits of the system’s hardware in presented. We 
also argue why the mm-wave range is beneficial for measuring concentration changes across mm-thick samples. 
The sensitivity of the sensor depends on both received power and the noise floor of the instrument, i.e. the signal 
to noise ratio (SNR). Second, we experimentally evaluate the system’s sensing capability using different types of 
controlled samples, such as attenuators, tanks with water-based glucose-loaded samples, and human tissues. To 
assess the glucose monitoring performance in the glucose loaded samples, the transmission across the tank filled 
with various concentrations of glucose solution has been measured and compared with pure water. The results 
show a satisfactory correlation between transmission coefficients and glucose concentration, and can detect as 
low as 0.025 wt% of glucose in water. Finally, we present in-vivo glucose sensing measurements in healthy humans 
undergoing a standard Intravenous Glucose Tolerance Test (IVGTT). The in-vivo results show that despite the 
signal uncertainty introduced by the human tissue, glucose spikes can be adequately detected with the present 
sensing system.
Results and Discussions
Estimated system sensitivity, uncertainty and optimal sensing frequency. Before evaluating our 
proposed system with experimental measurements, we provide estimates for two of its key aspects, its sensitiv-
ity and measurement uncertainty, which can assist in the choice of the system’s optimal sensing frequency. The 
system’s sensitivity is equivalent to the expected recorded transmission signal difference for a given change in 
the glucose concentration, measured in dB per wt% or dB/per (mmol/l). Since we utilize glucose dissolved in 
Figure 1. The sensor design and principles. (a) The mm-wave glucose sensor concept set-up with two patch 
antennas. The skin/blood/skin patient area or a tank is placed in between the two antennas. (b) A schematic of 
the sensor system with data and instruction flow controlled by Labview.
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water-based samples, its concentration can be measured as a percent (wt%) w/w in water, or simply through 
the weight of glucose (in mmol) per 1 l of water (mmol/l). For example, 1 wt% concentration is equivalent to 
55.6 mmol/l, given that glucose has a molecular weight of 180.2 g/mol. The measurement uncertainty of the devel-
oped system can be defined as the maximum measurement error in the recorded signal (in dB) which is allowed 
for sensing a given value of glucose concentration, given that the ISO: 15197:2013 standard allows a ± 0.86 mmol/l 
maximum error in measuring low blood glucose levels12.
Sensitivity. An order of magnitude estimate for the system sensitivity can be calculated as follows. For a change 
Δg in glucose concentration (in mmol/l or wt%), let ΔS21 be the measured amplitude variation of the transmitted 
signal S21 at frequency f, which propagates through a sample of thickness d. The dominating factor affecting the 
transmitted signal is the change of the imaginary part of the relative permittivity εg of dissolved glucose. The per-
mittivity εg typically follows a Debye distribution13, and the imaginary part of εg (εg″) decreases with increasing 
glucose concentration, leading to an increase ΔS21 in S21. The decrease in εg″ with increasing g is well known and 
has been measured by the authors10 and by other researchers14, 15. For example, a Δg = 1 wt% for d = 1 mm at 
60 GHz will decrease εg″ by ~0.23 units10.
The power transmission through a slab of glucose solution with complex permittivity εg (g, f) is dominated by 
the exponential loss factor as follows:
= | |ε−S dB e( ) 20 log , (1)jk d g f21
( , )g0
where k0 is the free space wavenumber at frequency f. This equation is valid under the following assumptions: (i) 
plane wave incidence; (ii) edge effects from the transverse slab boundaries are neglected; (iii) reflections from the 
air-slab interfaces are also neglected, and so is the presence of additional layers on either side of the glucose slab, 
such as plastic holding tank layers. In fact, when we calculated the S21 value with these additional layers present 
using more complex transmission formulas16, the difference in the sensitivity value was no more than 10% from 
the value presented below.
The complex permittivity of the glucose solutions as a function of both concentration (up to 5 wt%) and fre-
quency (in the 40–67 GHz range) was measured in earlier work by the authors10 and fitted using a 1st order Debye 





s . For example, the Debye parameters were calculated to be, ε∞ = 5.6184, εs = 78.5250 
and τ = 8.8601 ps for g = 1 wt%. The estimated sensitivity of the system for given values of d and g is calculated 
numerically from the above equation as
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This sensitivity value is mostly dependent on the Debye model of the glucose permittivity, and it is very weakly 
dependent on the glucose concentrations values and the slab thickness d. It also depends strongly on frequency: 
for a fixed slab thickness d, the factor k0d in the exponential of the equation above increases. Another way to view 
this is that the slab becomes electrically longer as the wavelength decreases, causing higher losses and thus larger 
differences in S21.
The values presented in the above equation are valid for relatively small values of g (up to 1%) and d (up to 
5 mm). As an example, for a tissue thickness of d = 2.5 mm, which is typical for human body sections such as the 
earlobe and the tissue between the fingers, and if a glucose change of Δg = 0.86 mmol/l is to be detected12, Eq. (2) 
above indicates that a signal of 0.010 dB should be reliably detected.
Uncertainty. To increase sensitivity, the difference in transmission data ΔS21 due to a glucose concentration 
change Δg should be as high as possible. For a given sample thickness d, Eq. (1) indicates that ΔS21 increases with 
frequency. The difference in the imaginary permittivity values for two different glucose concentrations will result 
in a higher ΔS21 for electrically longer samples, as illustrated in Fig. 2(a) (yellow line). The operational frequency, 
however, cannot be arbitrarily increased as electrically longer values will lead to smaller values for S21, which 
eventually will run into the noise floor of the sensing system and will not be accurately measured. It is well known 
that for Vector Network Analyzers (VNAs) the measurement uncertainty improves with increased Signal to Noise 
Ratio (SNR)17. For example, for the Keysight E8361 VNA used in our system, the measured dependence between 
uncertainty U and SNR at the receiving port for 10 Hz IF bandwidth is18
≈ . − . ∗U dB e[ ] 6 04 (3)SNR dB0 12 [ ]
From the above equation, a required uncertainty of 0.01 dB (necessary to detect a Δg = 0.86 mmol/l, as argued 
in the previous section) requires an SNR of 55 dB or better.
A higher SNR will lead to a smaller value of ΔSVNA that can be accurately measured. At the same time, operat-
ing at higher frequencies leads to lower SNR values, as the signal attenuates more for electrically longer samples. 
The end result is that the uncertainty of the sensing instrument, i.e. the smallest values of ΔS that can be reliably 
measured, or ΔSVNA, will also increase with frequency. This is shown also in Fig. 2(a) (green line).
Choosing the optimal sensing frequency. To achieve accurate glucose sensing, the sensing system should be 
designed in a way that its highest sensitivity (the ΔS value achieved at fopt) is above the ΔS21 due to the lowest 
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desired glucose change Δg that must be detected (for example, 0.86 mmol/l12). To provide a graphical interpre-
tation of this process, we have calculated the optimal frequency fopt for different values of sample thickness d and 
glucose concentration g in %, assuming that the glucose is dissolved in water. We investigated the frequency range 
of 20–100 GHz over which the Debye models for the permittivity of the different glucose concentrations are rela-
tively well known through measurements10 and the results are shown in 2(b).
The results in 2(b) consider that the power input onto the sample is 0 dBm, which is a typical output achieved 
by many modern VNAs. This value lies well below the IEEE safety radiation exposure limit for these frequencies, 
which is 20 dBm19. Moreover, the achievable noise floor value of our sensing system is set at −114 dBm. This value 
was measured in our experiments and is also in line with product specifications provided by the VNA manufac-
turer (Keysight). The transmission differences through the different samples were calculated using an analytical 
model of a transfer matrix method for transmission through multiple slabs15; however, the simplified Eq. (2) 
yields very similar results.
Figure 2(b) confirms that fopt decreases with increasing sample thickness, in order to maintain the electrical 
length of the sample. For the regions shown in white, the predicted fopt is above 100 GHz, for which accurate 
Debye model data for the glucose permittivity are not available. Also, fopt mostly increases with increasing Δg, 
with the exception of a region between Δg between 0.1 and 0.2. This behavior can be traced back to the Debye 
models obtained for particular glucose concentrations. Figure 2(b) can be used to provide an optimal frequency 
range for sensing glucose levels down to a minimum level of glucose concentration; for example, for a desired 
sensing accuracy of glucose change Δg = 0.86 mmol/l or higher, and a typical range of tissue thicknesses for hands 
2.5–4.0 mm, the highlighted region in Fig. 2(b) confirms that the optimal sensing frequency lies in the middle of 
the mm-wave spectrum, in the range of 40–80 GHz.
To summarize, Fig. 2(b) quantifies the theoretical analysis of this section which has argued that a frequency 
around 60 GHz is desirable for glucose detection using EM transmission data. For increasingly higher frequen-
cies, the losses are prohibitively high for the SNR to exceed the noise level of a sensing instrument such as a 
VNA, in order to maintain good measurement uncertainty. On the other hand, much lower frequencies result in 
changes in the glucose sample permittivity which are below the system sensitivity and cannot produce a measur-
able transmitted signal ΔS21.
Glucose sensing results in controlled environment. In this section, we examine the glucose sensing 
capabilities of the system. First, we investigate the limits in measurement uncertainty. Second, we study the effects 
of environment temperature and motion on the received S21 signals. Finally, we present glucose sensing data 
in controlled water-based glucose-loaded samples of varying concentration to estimate the low-concentration 
capabilities of the system.
Assesment of the measurement uncertainty of the system hardware. Considering for the moment that variations 
due to external factors are minimal, the inherent noise component of the signal affects the measurement as the 
noise adds either in-phase or out-of-phase to the measured signal. This error is independent of the quality of 
the instrument, as long as its noise floor is lower than the signal’s power level. If the received signal shows no 
distortion products and the VNA’s noise floor is below the signal with a sufficient dynamic range, the uncertainty 
depends solely on the signal to noise ratio (SNR) of the received signal.
In order to assess the received signal uncertainty as a function of the SNR, we compare three distinct measured 
quantities of uncertainty (the standard deviation or error) in Fig. 3: (i) The manufacturer-provided uncertainty of 
the VNA18, 20; (ii) The measured uncertainty of transmission measurements through a 1 mm-thick glucose-loaded 
water-based sample; iii) The measured uncertainty of transmission through human hand tissues of varying thick-
ness (and hence varying SNR).
The results in Fig. 3 show that good sensitivity levels, close to the ones can be provided by the VNA instru-
ment, are maintained when non-human samples are involved. The uncertainty curve deteriorates when meas-
uring transmission in human tissue due to the hand motion during measurement. Clearly, the uncertainty can 
Figure 2. Sensitivity and optimal frequency of operation. (a) Optimal frequency operating range considering 
difference in transmission coefficient and system uncertainty. (b) Optimal frequency of operation for different 
glucose concentrations and sample thicknesses.
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be improved with increasing SNR, and thus the resolution of detection be improved. For a fixed noise floor, the 
SNR can be improved by increasing the received signal and for a certain instrument the SNR can be enhanced 
by amplifying the signal after the source or before the receiver as the signal is transmitted through the sample.
Assuming a typical (for the Keysight VNA utilized in this work) SNR of 60 dB, the uncertainty of the system as 
shown in Fig. 3 is calculated to be 0.006 dB for non-human tissues. It can be seen that the smallest glucose levels 
that the sensing system hardware can detect is as small as 0.024 wt/wt in the water, or 1.33 mmol/l of concentra-
tion in blood (ΔS21 = 0.25 dB for 1% glucose solution for a 3-1-3 tank, as shown later in II.C). Thus, the glucose 
sensing system hardware is capable of resolving clinically meaningful blood glucose concentrations. However, the 
external errors, the environmental variables, the human tissue motion, and the true characteristics of the signal 
(power, noise level, spurs, etc.) will affect the sensitivity of the measurement. The sensitivity can be improved 
further using the full potential of the amplifier (∼10 dB gain), which would reduce the detection limit to one third 
(~0.4 mmol/l).
Assesing the impact of environmental factors. We have also measured the effect of environmental factors such as 
temperature and vibration on the transmission coefficient S21. To assess the temperature effects, a 20 dB attenuator 
was connected to the VNA and both ambient temperature and S21 were measured continuously over a period of 
two days. The recorded data are shown in Fig. 4(a). It can be seen that a negative temperature coefficient has been 
observed in S21, i.e. when the temperature increases S21 decreases and vice versa. This allows to correct the S21 for 
a certain sample to measure actual variations due to permittivity changes. We have also measured the variation 
in S21 with vibration on the cables, as shown in Fig. 4(b). The results show that there is no systematic drift with 
vibration other than the higher standard deviation (up to 2 dB) as vibration strengthens, which is more prominent 
at higher frequencies. The effect is more prominent in a non-phase stable cable (not shown). The current setup 
does not use this data to auto-correct the measurement results; however our future system will integrate data from 
Figure 3. Measurement uncertainty as a function of SNR: Different devices under test using the Keysight 
E8361A VNA. For the case of glucose-loaded water-based samples and hand, the SNR is calculated by dividing 
the received signal at port by the noise floor provided by Keysight from characterization data sheet.
Figure 4. The effect of environmental factor on measured data. (a) The variation in S21 and temperature for a 
20 dB attenuator recorded over a two days period. (b) The effects of vibration (movement) on the S21 through 
a 3-1-3 tank using phase-stable cables. The curves have been offset from the original values in the S21 axes to 
better illustrate the errors introduced. Steady state 1 and 2 means measurement before and after vibration.
www.nature.com/scientificreports/
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these sensors controlled by a LabVIEW interface to correct the RF measurement data and predict the dielectric 
constant or glucose concentration in real time.
Correlation of transmission data to glucose concentrations of water-based glucose-loaded samples. In this sec-
tion we present measurements of the transmission coefficient across an acrylic tank filled with a liquid glucose 
solution. The acrylic-spacer-acrylic tank has thicknesses of 3.0, 1.0, and 3.0 mm respectively (“3-1-3” tank), and 
is kept fixed during the measurements, as shown in the methods. A two-port calibration is performed using an 
electronic calibration kit before each set of measurements. Then, S21 is optimized to provide maximum transmis-
sion by moving the antennas symmetrically against the tank filled with deionized water. As shown in Fig. 5(a), 
maximum transmission was obtained when both antennas had minimum return loss. Having optimized S21 with 
water, the tank was filled with glucose solutions of various concentrations and the S parameters were recorded 
for each solution. The transmission coefficient for water was subtracted from that of various concentrations of 
glucose to get the absolute difference for each concentration.
Figure 5(b) shows the variation of ΔS21 for various concentrations of glucose at 58 GHz, where the trans-
mission is maximum. The ΔS21 in dB varies linearly with the glucose concentration. We have compared the 
experimental results with results both from 3-D EM simulations for various concentrations of glucose, as well as 
analytical calculations assuming plane wave propagation10. For both these calculations, the dielectric constant for 
each glucose concentration was obtained from measurements using a dielectric assessment kit (DAK), DAK-1.2E 
probe from SPEAG that operates up to 67 GHz. It can be seen that the measured ΔS21 results agree well with both 
simulation and analytical data. In particular, the plots in Fig. 5(b) suggest that ΔS21 is equal to around ~ 0.25 dB 
for each 1 wt% of glucose concentration, which matches the analytical and simulation data closely.
To show the capability of the device to detect clinically meaningful glucose levels for humans, the lower con-
centrations solutions are measured in both 3-1-3 and 3-2-3 tank and shown in Fig. 5(c). The linear relationship 
resembles the trend shown at higher concentrations. The lower than expected ΔS21 for thicker sample is attrib-
uted to surface wave that bypass the water/tissue, contributing to the overall transmission coefficient. The stand-
ard deviations from three consecutive measurements are also shown in the plot and these can be attributed to 
human imperfections during refilling the water tank, sample temperature variations, and the VNA drift due to 
temperature and other environmental factors which could be eliminated. The results show that a concentration 
as small as 0.025 wt% produces a detectable change on ΔS21 compared to adjacent concentrations, and could be 
used to detect human level glucose concentration in optimum measurement conditions.
Figure 5. The correlation between transmission coeffcient and glucose concentration. (a) Reflection and 
transmission coefficient vs. frequency for a 3-1-3 tank filled with pure water (b) ΔS21 for various glucose 
concentration from measurement, simulation and analytical calculation @ maximum trasnmission coefficient. 
(c) ΔS21 for 0–0.5% (smaller) glucose concentration from transmisison measurement for 3-1-3 and 3-2-3 tank 
@ maximum trasnmission coefficient. The plot has been shifted to zero for 0.025% since pure water (0%) is not 
seen in log scale. X axis has been plotted in log scale for both b & c to distinguish the lower concentrations. The 
error bar are standard deviation from three sets of measurements.
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In-vivo human clinical investigation and comparison with invasive methods. The sensing system 
was tested for real-time in-vivo blood glucose monitoring during human clinical investigation at the Department 
of Life Sciences, University of Roehampton, London, UK. Ten healthy male volunteers (n = 10) underwent an 
in-vivo Intravenous Glucose Tolerance Test (IVGTT). Blood glucose concentrations were continuously measured. 
Simultaneously to the sensing system attached to the volunteer’s right palm, blood samples were drawn from their 
left hand and measured with a lab analyser (Biosen C-line) at regular intervals, over a period of approximately 
60 minutes. Each session started with 5 min baseline measurements, followed by the administration of an iv glu-
cose load to the left arm over a 2-minutes-period, in order to create a physiological high blood glucose spike. The 
detailed protocol is described in Section D (Methods). The results presented good correlation between recorded 
transmission coefficient (S21) data and the reference data collected with the invasive method for two subjects 
(n = 10). Data collected from the other eight volunteers showed distortions in the received radio-frequency signal 
suggesting hand motion and gradual sliding of the holder during the session, possibly because of fatigue or stress.
Figure 6 shows an example comparison between the continuous non-invasive glucose reading and the data 
collected invasively for a volunteer that produced good correlation. The variation in transmission coefficient 
(S21) with time follows the trend closely shown by invasive method, successfully detecting the glucose spike. 
The glucose concertation as measured by the reference method increases from 6 mmol/l to 30 mmol/l, a change 
of 24 mmol/l. Based on the theoretical calculations and the controlled sample sensing measurements presented 
in earlier sections, where a 0.00047 dB change per mm of tissue thickness for every mmol/l of glucose change is 
expected, we can make an order-of-magnitude estimate of the expected change in S21 due to the produced glu-
cose spike. Using the 5 mm-thick value for the particular subject’s tissue thickness, the expected total change is 
ΔS21 = 0.0047 dB/(mm*mmol/l) * 5 mm * 24 mmol/l = 0.56 dB. In the investigation, a change of 0.8 dB was meas-
ured, which falls within the order-of-magnitude estimate. The difference is attributed to the possibly higher actual 
glucose concentration at the hand location that the sensing system was placed, and the more complex structure of 
the human tissue than the one assumed in earlier the calculations21.
The reference invasive method shows that the glucose spike occurred during the 9th min. According to the S21 
measured signal, the spike is observed during the 12th min. The 3 min delay for the S21 spike is attributed to the 
time required for the blood to flow from hand to palm22. In addition, while for the invasive method the blood 
was collected from the vein, the sensing system was attached to and measured from peripheral region inducing 
further delay. The current device did not measure specificity of glucose over other substance in blood; however 
the device specificity of glucose over salt has been shown in an earlier piece of work by the authors10. Future work 
would include improving the repeatability, measure lower concentration of glucose in-vivo and specificity of 
glucose over various blood substances.
In conclusion, we have developed a miniature prototype for mm-wave dielectric permittivity measurements 
with focus on biomedical applications, which is herein studied for the detection of glucose concentrations in 
liquid samples and in-vivo human subjects. A set of 1.50 mm by 1.50 mm square patches have been designed and 
fabricated to be used as both transmitter and receiver element with a VNA. The prototype has been used to meas-
ure various concentrations of glucose solution contained in an acrylic tank. The measured ΔS21 relative to pure 
water changes linearly with glucose concentration, and the sensitivity per 1% substance match theoretical limits 
and are comparable to waveguide-based measured data. The device has performed in-vivo clinical investigation 
in human and successfully measured larger glucose level induced by intravenous glucose load. Based on these 
findings, the development of a complete miniature handheld device is under way, where the VNA will be replaced 
by a compact and integrated source and detector. In order to increase the sensitivity for thicker samples and 
hand tissue, absorber will be used around the antenna to block the surface wave bypassing the region of interest 
i.e. tissue or glucose solution. Environmental effects have also been integrated in the development of the sensing 
system, with the goal to cancel the impact of heat and motion/vibration in the measurements.
Beyond biomedical applications, the proposed sensing system can be used in applications where continu-
ous monitoring of changes in the dielectric constant or conductivity of a liquid is required, for example allow-
ing real-time monitoring of changes in the substance of a specific container without opening it. Our driving 
Figure 6. The in-vivo measurements results and comparison with invasive methods. The relation between 
measured transmission coefficient and glucose reading from a conventional glucose meter with time. There is a 
delay (~3 min) in the glucose spike between invasive method and our peripheral data. GlucoWise’s conversion 
to mmol/l matches well with the invasive methods. The trial was conducted at Roehampton University, London.
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healthcare application is continuous monitoring of glucose levels in diabetic patients without the need of drawing 
blood, where we have targeted an accuracy of 0.025 wt% of glucose in blood.
Methods
System design. As mentioned in the Introduction, the main components of this mm-wave permittivity 
measurement system is a pair of 60 GHz antennas, which are powered and measured using a Keysight E8361A 
VNA. To monitor external effects which could lead to variations in the performance of the sensor especially in 
live biological measurements, environmental sensors were mounted within the antenna holder (see Fig. 1(b)). 
This set of sensors includes two thermometers (one to measure the sample or skin temperature, and one to mon-
itor the ambient air temperature), and a solid-state three-axis accelerometer to detect movement. These sensors 
were monitored and controlled by National Instruments data acquisition hardware (DAQ) which in turn com-
municated to a computer running LabVIEW. An in-house LabVIEW program was developed so that the VNA 
S-parameter results can be viewed alongside the sample/skin and air temperature and sample/skin movement as 
a function of time. This feature can assist in removing external ambient effects, for example by allowing data to 
be removed at times when anomalous vibration is observed. In future work, the sensors will be used to correct or 
modify the data, thereby performing a real-time system calibration.
Standalone Antenna Simulation, Fabrication and Characterization. Rectangular microstrip patch 
antennas have been designed as the basic element for the sensor, with a Rogers 5880 substrate material of 254 μm 
thickness 2.2 of dielectric constant and 0.0009 loss tangent23. The antenna was fed from the back side, as side 
feeds produced inconsistent results and did not guarantee robustness. We first calculated the design parameters 
of the patch antenna (length and width of the patch) by using well-known theoretical equations16, for our given 
substrate and desired frequency of 60 GHz. Subsequently, these parameters were optimized in CST simulations 
to minimize the antenna return loss (S11), yielding a patch with approximate dimensions of 1.50 by 1.50 mm, as 
briefly described in an earlier piece of abstract24. The final fabricated prototype is as shown in Fig. 7(a), while the 
calculated three-dimensional (3-D) patterns of the realized gain at 60 GHz is shown in Fig. 7(b). A maximum 
realized gain of 7.77 dBi is obtained at 60 GHz. The radiation pattern is symmetrical in the H-plane and fraction-
ally asymmetrical in the E-plane. The radiation efficiency of the single element is around −0.025 dB (99%) for the 
operating bandwidth.
For experimental characterization, the square patch antenna was mounted on a V-band connector 380P12F5 
(SigaTek) and was measured using the VNA. Figure 7(c) shows the simulated and measured S11. The measured 
resonant frequency of 60.25 GHz is very close to the simulated result of 60 GHz. The small deviation can be attrib-
uted to fabrication tolerance and soldering imperfections. The measured return loss is higher and the operating 
bandwidth is wider (approx. 10 GHz for S11 ≤ −10 dB) compared to the simulation results. The broad bandwidth 
can provide a reasonable frequency window to characterize the blood glucose level or a specific substance in a 
Figure 7. The antenna design, simulation and characterization. (a) Photo of the square patch, soldered from 
the back side. (b) Simulated 3D radiation pattern of the antenna gain at 60 GHz, which is the desired operating 
frequency of the antenna. (c) Free space simulated and measured return loss (S11) for the antenna of Fig. (a).
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liquid, and can compensate for any frequency detuning from the antenna’s resonance when placed in close prox-
imity to the skin or sample tank.
Mechanical setup for the portable sensor. To realize a precision measurement system at these high 
frequencies, the antennas are mounted on a custom-made portable holder as shown in Fig. 8, which comprises a 
base, two three-axis micro positioners, and two custom 3-D printed holders. The tank is mounted on a post, and 
both antennas are mounted facing each other on a one-axis micro positioner with a step adjustment of 10 µm. 
A three-axis micro positioner equipped with a coarse and fine adjustment range of 500 μm/rev and 50 μm/rev, 
respectively, sits below the one-axis positioner. The custom-made 3D-printed extensions are placed on the micro 
positioner to avoid metal interference and prevent the antenna from any unwanted movement due to vibration. 
The antennas can move in all three directions independently in order to optimize the transmission coefficient S21 
across the tank by achieving precise alignment.
Figure 8. The mechanical setup. The measurement assembly containing two sets of 3-D printed holder and 
two sets of micro-positioner. The positioners are attached on a plate (optical table). The whole sensor can be 
mounted on a three axis rotational arm to align precisely against hand or ear lobe for human trial.
Figure 9. The setup for in-vivo glucose measurements in humans. The non-invasive system is placed across the 
thin tissue of right hand. Glucose was administered intravenously through the left arm. The same cannula was 
used to collect blood samples for measuring glucose levels during a specific amount of time.
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Human clinical investigation preparation and measurments. Ten healthy male subjects (n = 10, 
mean ± SD; age 35 ± 11 years, BMI 26.6 ± 2.5 kg/m2 and body fat 23.5 ± 7.6%) underwent an Intravenous 
Glucose Tolerance Test (IVGTT)25, 26 during the clinical investigation of the non-invasive glucose sensing system 
that took place at the Department of Life Sciences, University of Roehampton, London, UK. During the test, the 
glucose levels of the volunteers were monitored by drawing blood at regular intervals and measured it using a lab 
analyser (Biosen C-line)27. The experiments were approved by University of Roehampton ethics committee and 
all experiments were performed in accordance with relevant guidelines and regulations.
The sensing system under investigation was placed on the right hand, in order to measure the signal variation 
of the thin tissue between the index and thumb fingers (Fig. 9). After placing the hand on the system, the antenna 
distance was adjusted so that a maximum transmission (S21) was obtained in the frequency spectrum where both 
antennas have a minimum reflection coefficient (S11/S22).
After 5 minutes baseline measurements, the sterile iv glucose load (250 mg/kg body mass; 50% glucose 0.9% 
NaCl saline) was administered intravenously over a period of 2 minutes via and indwelling 18″ cannula placed 
into a prominent contralateral antecubital vein on the left arm of each volunteer (Fig. 9). Blood was drawn at 0 
and 5 minutes and at every 1 minute for the first 10 minutes after the glucose administration. After this period, the 
sampling frequency was every 2–5 minutes, while the non-invasive system was continuously collecting data. The 
test continued for approx. 60 minutes, until the glucose levels returned to normal (below 7 mmol/l) as determined 
by the reference instrument.
Experiments involving human participants. Authors confirms that informed consent was obtained 
from all participants and University of Roehampton ethics committee approved the human clinical investigation.
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